Stockreport

Renalys Pharma Submits an IND Application for a Phase III Clinical Trial of sparsentan for IgA Nephropathy in Japan [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF Investigational New Drug (IND) Application for sparsentan to the Pharmaceuticals and Medical Devices Agency (PMDA) for a Phase III clinical trial in Japan The Phase II [Read more]